Galaxy Diagnostics: Funding, Investors & Team (Nov 2026)
Galaxy Diagnostics is an early-stage infectious disease diagnostic company, specializing in the detection of Bartonella. Bartonella is bacteria that cause zoonotic infections – i.e., Bartonella may be transmitted from an animal host (usually a cat) to people. Vectors, like fleas, lice, ticks, and biting flies also play an important role in transmission. People who work and live with animals are at higher risk of infection. Bartonella are a key agents in Cat Scratch Disease and a few other known diseases. Bartonella was recently (re)discovered in HIV patients in the 1990s and found to cause of many life-threatening complications in HIV patients, including skin rashes and heart and liver infections. Galaxy Diagnostics was founded in 2009 and is based in Durham, North Carolina, United States.
Galaxy Diagnostics has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Jun 2026.
That round is below the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Galaxy Diagnostics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Galaxy Diagnostics Funding Rounds
Galaxy Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Galaxy Diagnostics Funding Compared to Other Biotechnology Startups
Galaxy Diagnostics' latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Galaxy Diagnostics in Biotechnology and Durham
Companies Similar to Galaxy Diagnostics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Galaxy Diagnostics Funding FAQs
What does Galaxy Diagnostics do?
Galaxy Diagnostics is an early-stage infectious disease diagnostic company, specializing in the detection of Bartonella. Bartonella is bacteria that cause zoonotic infections – i.e., Bartonella may be transmitted from an animal host (usually a cat) to people. Vectors, like fleas, lice, ticks, and biting flies also play an important role in transmission. People who work and live with animals are at higher risk of infection. Bartonella are a key agents in Cat Scratch Disease and a few other known diseases. Bartonella was recently (re)discovered in HIV patients in the 1990s and found to cause of many life-threatening complications in HIV patients, including skin rashes and heart and liver infections. Galaxy Diagnostics was founded in 2009 and is based in Durham, North Carolina, United States.
How much funding has Galaxy Diagnostics raised?
Galaxy Diagnostics has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Jun 2026.
When did Galaxy Diagnostics last raise funding?
Galaxy Diagnostics' most recent funding round on record is an undisclosed round of $3.0M, announced in Jun 2026.
Who founded Galaxy Diagnostics?
FundedIQ lists Nicole Bell (Founder) at Galaxy Diagnostics.
Where is Galaxy Diagnostics headquartered?
Galaxy Diagnostics is based in Durham, North Carolina, United States.
How many employees does Galaxy Diagnostics have?
Galaxy Diagnostics is in the 11-50 employee band.
How does Galaxy Diagnostics' funding compare to other Biotechnology startups?
Galaxy Diagnostics' latest round of $3.0M is below the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Galaxy Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Galaxy Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.